Palmer & Dodge LLP

2001 Biotech Predictions

The Power Of Outsourcing

Q&A On Reverse Licensing

Advice Of Counsel : Q&A On Tech Transfer

G2C: The Genomics To Consumer Model

Know The Perils Of Technology Transfer

Transatlantic Merger Fever

Advice Of Counsel - Q&A On Tech Transfer : Are There Unique Legal Problems Distinguishing European-American Biotech Acquisitions From Those In Which The Buyer Is An American Biotech?

Q&A On Tech Transfer

B2B Revolution Is Reaching Biotech

The Triumphs And The Ongoing Tribulations Of Gene Therapy

Advice of Counsel April 2000- Q&A On Tech Transfer - What is the state of the law concerning the patentability of gene sequences and the proteins which they encode, in view of the recent statements by President Clinton and Prime Minister Blair?

Advice of Counsel March 2000 - Is there anything different about current public offerings when contrasted with prior boom periods in the industry?

Advice of Counsel February 2000- Q&A On Tech Transfer - I Understand That Co-Promotion Deals Are Becoming More Common. What Are The Key Terms Of A Co-Promotion Deal?

Market is hot for biotech

Advice of Counsel January 2000- Q&A On Tech Transfer - Were Any New Biotech Business Models Developed In 1999 That We Can Expect To Continue To See In The New Year?

Advice of Counsel November 1999 - Q&A On Tech Transfer - Which issues typically arise after the signing of a merger agreement, which can jeopardize the closing of a transaction?

Advice of Counsel December 1999 - Q&A On Tech Transfer - A number of US bio-tech companies are setting up subsidiaries in Germany; is this something we should consider?

Resolutions For A Biotech New Year

Net is changing the biomed industry